[{"NetIncomeLoss_1_Q1_USD":-46205000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":21215000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-12000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":413258000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-25542000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":1645823.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":70000.0,"AssetsCurrent_0_Q1_USD":601084000.0,"MarketableSecuritiesRealizedGainLoss_1_Q1_USD":0.0,"ContractWithCustomerLiability_0_Q1_USD":68373000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7922000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":13340000.0,"CommonStockSharesIssued_0_Q1_shares":67890334.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":459260000.0,"Assets_0_Q1_USD":716891000.0,"ShareBasedCompensation_1_Q1_USD":6424000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":77912000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":20.71,"ProceedsFromIssuanceOfCommonStock_24_Q1_USD":1165300000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":36.64,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":5448000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"CommonStockSharesAuthorized_0_Q1_shares":120000000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":67183000.0,"MarketableSecuritiesCurrent_0_Q1_USD":442525000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":39276000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":25.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1_Q1_shares":259839.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-4588000.0,"AccountsReceivableNetCurrent_0_Q1_USD":953000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.72,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q1_USD":43.69,"CommonStockValue_0_Q1_USD":7000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1591000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":58595000.0,"CostsAndExpenses_1_Q1_USD":52870000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":125200000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-46218000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-917000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.009,"OtherAssetsNoncurrent_0_Q1_USD":5003000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":141538000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":64487000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1027192000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q1_shares":442740.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":57.71,"GeneralAndAdministrativeExpense_1_Q1_USD":13594000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-5558000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":6445000.0,"ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_1_Q1_USD":-5558000.0,"CommonStockSharesOutstanding_0_Q1_shares":67890334.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":148330000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":5558000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-13000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":58000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":6424000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q1_USD":-13000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-52376000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":16735000.0,"LiabilitiesCurrent_0_Q1_USD":60702000.0,"AccountsPayableCurrent_0_Q1_USD":8688000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":16068000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":13340000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":2128000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":255000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":145283000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":1014569.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":901000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_24_Q1_USD":85000000.0,"RestrictedCashEquivalents_0_Q1_USD":3745000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":16157000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-1177000.0,"OperatingIncomeLoss_1_Q1_USD":-46425000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-19323000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":2734966.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":54800000.0,"InvestmentIncomeInterest_1_Q1_USD":220000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":22544000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":57.94,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":13.15,"LiabilitiesAndStockholdersEquity_0_Q1_USD":716891000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":6244000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":6424000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":86900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":129393.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":8255000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_0_Q1_USD":17800000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.69,"ProfitLoss_1_Q1_USD":-46205000.0,"StockholdersEquity_0_Q1_USD":545873000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":45829000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":2412000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":459272000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-1209000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":7479301.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-481314000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":2833000.0,"Ticker":"NTLA","CIK":"1652130","name":"INTELLIA THERAPEUTICS, INC.","OfficialName":"Intellia Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4259315236.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]